Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

122 results
Display

Preoperative Treatment with Lugol Solution for Graves' Disease

Makay O, Sun H, Caruso E, Pino A, Pontin A, Mandolfino T, Dionigi G

Graves' disease is one of the commonest causes of hyperthyroidism. Pre-treatment with Lugol solution, containing iodine/potassium iodide, to induce euthyroidism before surgery may be suggested, especially in case of adverse...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Updates of Radioiodine Treatment for Graves' Disease

Jeong SY

Radioiodine (RAI) has been used for the treatment of hyperthyroidism and is usually administered orally as sodium iodide (I-131) in solution or a capsule. However, this results in RAI being...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical Treatment of Graves' Disease

Chung HK

Among the three treatment modalities of Graves' disease which include antithyroid drug (ATD), radioactive iodine and surgery, the ATD is most commonly preferred in Korea due to ease of use...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Massive cerebral venous sinus thrombosis secondary to Graves' disease

Son HM

Cerebral venous sinus thrombosis (CVT) is a rare cerebrovascular condition accounting for 0.5–1% of all types of strokes in the general population. Hyperthyroidism is associated with procoagulant and antifibrinolytic activity,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
It Sometimes Happens: Staging Surgery in Coexisting Graves' Disease and Thyroid Cancer

Caruso E, De Pasquale M, Pino A, Bartolo V, Famà F, Ieni A, Dionigi G

Thyroidectomy is a safe procedure often performed either for benign or malignant thyroid diseases. Complication rate is low and bilateral recurrent laryngeal nerve (RLN) injury associated with thyroidectomy is rarely...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy

Choi YM, Kwak MK, Hong SM, Hong EG

BACKGROUND: Graves' disease (GD) is an autoimmune thyroid disorder caused by antibodies stimulating the thyrotropin (TSH) receptor. TSH receptor antibody (TRAb) measurement is useful for predicting GD relapse after antithyroid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Thyrotoxic hypokalemic periodic paralysis due to Graves' disease in 2 adolescents

Roh JG, Park KJ, Lee HS, Hwang JS

Thyrotoxic periodic paralysis (TPP) is a notable and potentially lethal complication of thyrotoxicosis, and Graves' disease is the most common cause of TPP. TPP is commonly reported in Asian males...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Graves' Disease: Can It Be Cured?

Wiersinga

Whether or not Graves' hyperthyroidism can be really cured, depends on the definition of “cure.” If eradication of thyroid hormone excess suffices for the label “cure,” then all patients can...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Graves' Disease Patients with Large Goiters Respond Best to Radioactive Iodine Doses of at Least 15 mCi: a Sonographic Volumetric Study

Jeong YA, Yoon JH, Kim HK, Kang HC

BACKGROUND AND OBJECTIVES: Radioactive iodine therapy (RAI) is an important treatment modality of Graves' disease (GD), but there is still not a consensus on the optimal dosage regimen. We studied...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Graves' Disease Accompanied with Acute Hepatitis A Virus Infection

Hong SE, Choo JW, Lim SK, Lee SJ, Park JW, Kim SE, Kim JH, Park CK

Concurrent presentation of acute hepatitis A virus (HAV) infection and Graves' disease has not been reported in literature worldwide. Although there is no well-established mechanism that explains the induction of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
RE: Novel Application of Quantitative Single-Photon Emission Computed Tomography/Computed Tomography to Predict Early Response to Methimazole in Graves' Disease

Zhang W, Huang ZQ, Lin WL, Yang SH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Recurrence Rate of Graves' Disease among Patients with Subclinical Thyrotoxicosis after Initial Remission with Antithyroid Agents

Shim MS, Nam SM, Yoo JS, Kim HK, Lee SJ, Lee MY

BACKGROUND AND OBJECTIVES: The recurrence rate of patients with Graves' disease (GD) is estimated to be 50-55% after withdrawal of antithyroid drug therapy, and relapse is frequent in the first...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease

Choi HS, Yoo WS

BACKGROUND: Anti-thyroid drug therapy is considered a treatment of choice for Graves' disease; however, treatment response varies among individuals. Although several studies have reported risk factors for relapse after initial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sweet's Syndrome Associated with Graves' Disease

Yong HJ, Kang MI, Kim D

Sweet's syndrome, or acute febrile neutrophilic dermatosis, occurs in association with autoimmune diseases such as Hashimoto's thyroiditis but is rare in Graves' disease, in which all cases are induced by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cerebral Venous Thrombosis in a Patient with Graves' Disease

Kim BR, Jung JH, Hahm JR, Jung J, Park HJ, Kim SK

Superior sagittal sinus thrombosis is an uncommon disease, and 25% of cases are considered to be idiopathic. Hypercoagulability, local bloodstream stasis, and vessel wall abnormalities may contribute to the development...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Methimazole-Resistant Severe Graves' Disease: Dramatic Response to Cholestyramine

Chae SB, Kim ES, Lee YI, Min BR

A 22-year-old woman with severe Graves' disease was referred from a local clinic because of her refractory hyperthyroidism. She presented with exophthalmos, diffuse goiter, and tachycardia. She was treated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Graves' Disease Presented with Atypical Symptoms

Yoo WS, Chung HK

We describe here two Graves' patients who have presented with atypical symptoms. Interestingly, both of them had symptoms related to imbalance of body fluid homeostasis. Chief complaint of a 35-year-old...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Encephalopathy Associated with Autoimmune Thyroid Disease Accompanied by Graves' Disease

Park KS, Lee SH, Cho NY, Choi YA, Ko YM, Nam SW, Nam SM

A patient with encephalopathy associated with autoimmune thyroid disease (EAATD), which is one of the most important differential diagnoses of treatable dementia, presents with various neurological symptoms, such as repetitive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in bone mineral density and trabecular bone score in Graves' disease patients after anti-thyroid therapy

Ock SY, Chung YS, Choi YJ

OBJECTIVE: The purpose of this study was to evaluate changes in bone quantity based on bone mineral density (BMD) and bone quality based on trabecular bone score (TBS) in Graves'...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dilated cardiomyopathy with Graves disease in a young child

Choi YJ, Jang JH, Park SH, Oh JH, Koh DK

Graves disease (GD) can lead to complications such as cardiac arrhythmia and heart failure. Although dilated cardiomyopathy (DCMP) has been occasionally reported in adults with GD, it is rare in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr